Dow Down 0.92% Nasdaq Down 0.83%

Novogen Limited (NVGN)

-NasdaqCM
2.87 Up 0.10(3.64%) 3:51PM EDT
Prev Close:2.77
Open:2.74
Bid:1.87 x 1000
Ask:N/A
1y Target Est:N/A
Beta:-1.58
Next Earnings Date:N/A
Day's Range:2.74 - 3.20
52wk Range:2.68 - 6.84
Volume:91,671
Avg Vol (3m):12,403
Market Cap:19.35M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):49.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback